시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 심상성 천포창 시장 보고서(2025년)
Pemphigus Vulgaris Global Market Report 2025
상품코드 : 1730986
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,686,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,665,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,644,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 심상성 천포창 시장 규모는 향후 수년간 강력한 성장이 전망될 예정입니다. 앞으로는 임상시험 증가, 정밀의료 발전, 디지털 헬스 솔루션 성장, 생물제제 수요 증가, 원격의료의 이용 확대 등이 예측 기간의 성장을 견인할 것으로 보입니다.

자가면역 질환의 유병률 증가는 향후 수년간 심상성 천창 시장의 성장을 가속할 것으로 예측됩니다. 자기면역질환의 가족력이 있는 사람은 면역시스템의 취약성이 유전되기 때문에 자가면역질환을 발병할 가능성이 높습니다. 2025년 1월 Mayo Clinic Health System에 의하면, 자가면역질환의 세계 발생률과 유병률은 모두 증가하고 있으며, 연간 증가율은 각각 19.1%와 12.5%로 추정되고 있습니다.

심상성 천포창 시장의 주요 기업은 치료 옵션의 확대를 목표로 하는 솔루션에 투자하고 있습니다. Patient Access Network(PAN) 재단은 2023년 1월 대상인 심상성 천포창 환자에게 연간 최대 6,600달러를 제공하는 재정지원 프로그램을 시작했습니다. 이 지원은 공제액, 자기부담액, 공동 부담액을 커버하는 것이며, 심상성 천포창 치료를 받고 있는 것, 필요한 약을 커버하는 메디케어 보험에 가입하고 있는 것, 연방 빈곤 레벨의 400% 이하의 소득이 있는 것 등이 자격 조건이 되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

JHS
영문 목차

영문목차

Pemphigus vulgaris is a rare autoimmune disorder that causes blistering and sores on the skin and mucous membranes, including the mouth, throat, and genitals. It occurs when the immune system mistakenly targets the proteins that hold skin cells together, leading to the formation of painful blisters. These blisters can rupture easily, resulting in raw, open sores. Pemphigus vulgaris is a chronic condition and can be life-threatening if not treated properly, usually with immunosuppressive medications to regulate the immune system's abnormal response.

The primary methods for diagnosing and treating pemphigus vulgaris include clinical evaluation, skin biopsy, and immunological tests to detect autoantibodies. The condition can affect various age groups, including pediatrics, adults, and geriatrics. Treatment is distributed through several channels, including hospitals, retail pharmacies, and online pharmacies. It is used by various end-users such as hospitals, specialty clinics, research institutes, and others.

The pemphigus vulgaris market research report is one of a series of new reports from The Business Research Company that provides pemphigus vulgaris market statistics, including the pemphigus vulgaris industry global market size, regional shares, competitors with the pemphigus vulgaris market share, detailed pemphigus vulgaris market segments, market trends, and opportunities, and any further data you may need to thrive in the pemphigus vulgaris industry. This pemphigus vulgaris market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pemphigus vulgaris market size has grown strongly in recent years. It will grow from $1.80 billion in 2024 to $1.95 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth observed during the historical period can be attributed to factors such as the increasing adoption of biologic therapies, a rising incidence of genetic predisposition, the growing prevalence of pemphigus vulgaris, the expanding role of biosimilars, and improvements in healthcare infrastructure.

The pemphigus vulgaris market size is expected to see strong growth in the next few years. It will grow to $2.63 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. Looking ahead, the growth in the forecast period is expected to be driven by an increase in clinical trials, advancements in precision medicine, the growth of digital health solutions, higher demand for biologics, and the expanded use of telemedicine. Key trends for the forecast period include advancements in biologic therapies, regulatory approvals, the adoption of combination therapies, progress in personalized medicine, and innovations in oral formulations of biologic therapies.

The increasing prevalence of autoimmune diseases is expected to drive the growth of the pemphigus vulgaris market in the coming years. Autoimmune diseases occur when the immune system mistakenly attacks the body's own healthy cells, tissues, or organs. This rise in prevalence is influenced by genetic factors, environmental triggers, and lifestyle changes. Individuals with a family history of autoimmune diseases are more likely to develop them due to inherited vulnerabilities in their immune system. As autoimmune diseases become more widespread, including conditions such as pemphigus vulgaris, there is a greater demand for advanced therapies to manage these disorders. For instance, according to Mayo Clinic Health System in January 2025, the global incidence and prevalence of autoimmune diseases are both increasing, with annual increases estimated at 19.1% and 12.5%, respectively. As a result, the growing prevalence of autoimmune diseases is fueling the expansion of the pemphigus vulgaris market.

Major companies in the pemphigus vulgaris market are investing in solutions aimed at expanding therapeutic options. These investment solutions involve financial strategies and resources allocated to treatment development, research, and market introduction. For example, in January 2023, the Patient Access Network (PAN) Foundation, a U.S.-based non-profit organization, launched a financial assistance program that offers up to $6,600 annually for eligible pemphigus vulgaris patients. This assistance covers deductibles, copays, and coinsurance costs, with eligibility criteria including treatment for pemphigus vulgaris, Medicare insurance that covers necessary medications, and an income at or below 400% of the federal poverty level. The PAN Foundation also provides transportation assistance and connects patients with support organizations.

In December 2023, PAN Foundation partnered with the International Pemphigus & Pemphigoid Foundation to offer financial aid and support to pemphigus vulgaris patients. Through this partnership, the PAN Foundation continues to provide financial assistance of up to $6,600, along with access to educational resources and support services, aiming to alleviate the financial burden of treatment and improve the quality of life for affected individuals. The International Pemphigus and Pemphigoid Foundation is a U.S.-based non-profit organization that provides resources and solutions for pemphigus vulgaris patients.

Major players in the pemphigus vulgaris market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Amgen Inc., Sanofi S.A, Biogen Inc., Genentech, Genmab A/S, argenx SE, Daewoong Pharmaceutical Co. Ltd., HanAll Biopharma Co. Ltd., Artiva Biotherapeutics, Cabaletta Bio Inc., SinoMab BioScience Limited, Topas Therapeutics GmbH, Principia Biopharma Inc., Serpin Pharma LLC, Syntimmune Inc., International Pemphigus & Pemphigoid Foundation.

North America was the largest region in the pemphigus vulgaris market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pemphigus vulgaris report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pemphigus vulgaris market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pemphigus vulgaris market consists of revenues earned by entities by providing services such as physical therapy, palliative care, patient support groups, psychological support and counseling, and immunosuppressive therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. The pemphigus vulgaris market includes sales of skin biopsy kits and serological test kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pemphigus Vulgaris Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pemphigus vulgaris market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for pemphigus vulgaris ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pemphigus vulgaris market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Pemphigus Vulgaris Market Characteristics

3. Pemphigus Vulgaris Market Trends And Strategies

4. Pemphigus Vulgaris Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Pemphigus Vulgaris Growth Analysis And Strategic Analysis Framework

6. Pemphigus Vulgaris Market Segmentation

7. Pemphigus Vulgaris Market Regional And Country Analysis

8. Asia-Pacific Pemphigus Vulgaris Market

9. China Pemphigus Vulgaris Market

10. India Pemphigus Vulgaris Market

11. Japan Pemphigus Vulgaris Market

12. Australia Pemphigus Vulgaris Market

13. Indonesia Pemphigus Vulgaris Market

14. South Korea Pemphigus Vulgaris Market

15. Western Europe Pemphigus Vulgaris Market

16. UK Pemphigus Vulgaris Market

17. Germany Pemphigus Vulgaris Market

18. France Pemphigus Vulgaris Market

19. Italy Pemphigus Vulgaris Market

20. Spain Pemphigus Vulgaris Market

21. Eastern Europe Pemphigus Vulgaris Market

22. Russia Pemphigus Vulgaris Market

23. North America Pemphigus Vulgaris Market

24. USA Pemphigus Vulgaris Market

25. Canada Pemphigus Vulgaris Market

26. South America Pemphigus Vulgaris Market

27. Brazil Pemphigus Vulgaris Market

28. Middle East Pemphigus Vulgaris Market

29. Africa Pemphigus Vulgaris Market

30. Pemphigus Vulgaris Market Competitive Landscape And Company Profiles

31. Pemphigus Vulgaris Market Other Major And Innovative Companies

32. Global Pemphigus Vulgaris Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pemphigus Vulgaris Market

34. Recent Developments In The Pemphigus Vulgaris Market

35. Pemphigus Vulgaris Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기